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Objectives

Classes of Anticoagulants

Risk Factors and Prevention

1. Understand the mechanisms, indications, and contraindications of
the classes of anticoagulants.
2. Review common clinical indications, contraindications, and side
effects for heparin and warfarin administration in the perioperative patient.
3. Review surgical indications for anticoagulants based upon the
nature of the procedure.
4. Review when to introduce an anticoagulant in the perioperative
patient in the clinical setting.

Vitamin K antagonists (VKAs) inhibit the vitamin K-dependent factors II, VII, IX, X,
protein C, S, and Z in the coagulation cascade. VKAs require regular monitoring to
tailor a therapeutic dose that keeps the patients’ INR between 2.0-3.0. There is data
available that suggests VKAs are only effectively anticoagulated roughly 60% of the
time due to this narrow range (Zirlik et al, 2016). Contraindications to using VKAs
include patients with hemorrhagic stroke or clinically significant bleeding, use within
72 hours of major surgery with severe bleeding risk, and 48 hours postpartum.
Heparins bind to only soluble thrombin; this class includes fondaparinux, lowmolecular weight heparin (dalteparin and enoxaparin), and unfractionated heparin
(Morales-Vidal et al, 2012). Heparin is administered intravenously (IV) or
subcutaneously (SQ); IV is used for continuous administration, whereas SQ is used to
prevent thromboembolism. Contraindications to use of heparin include a platelet count
of 100,000 or less, no routine access to INR monitoring, uncontrollable bleeding, or a
history of heparin-induced thrombocytopenia.
Direct oral anticoagulants (DOACs), are indicated for stroke prevention in nonvalvular atrial fibrillation and for treatment and prevention of DVT’s and PE’s. They
can be divided into two categories: direct thrombin inhibitors and direct factor Xa
inhibitors. DOACs have more predictable pharmacokinetics and lower potential for
drug or food interactions than VKAs with similar anticoagulant efficacy, which make
them a more attractive alternative. DOACs are renally eliminated, however, and must
be used with caution in patients with renal disease; creatinine clearance should not be
below 30 (Zirlik et al, 2016). Contraindications to using DOACs include valvular atrial
fibrillation, clinically significant active bleeding, hepatic disease associated with
coagulopathy, lesions such as gastric ulcerations, malignant neoplasms, recent brain,
spinal, or ophthalmic injury, arteriovenous malformations, uncontrolled hypertension,
pregnancy and breast feeding(Warnock et al, 2022).

Coagulopathy is a multi-factorial condition. There are also many clinical
conditions and diseases that can predispose a patient to hypercoagulability:
age, previous thrombosis, immobilization, major surgery (primarily
orthopedic), malignancy, OCPs, pregnancy, and HRT, to name a few
(Bande et al, 2014). The reasoning behind prophylactic anticoagulation is
to prevent thrombosis that could be life threating or result in chronic
complications; pulmonary embolism is the most common cause of
preventable death in post-operative hospitalized patients (Finnerty et al,
2011). Therefore, a multi-modal approach is used in preventing DVTs and
PEs in the post-operative patient. Intermittent pneumatic compression
devices have been found to be comparable to anticoagulation in joint
arthroplasty patients with a thrombotic risk of 1.39%. Concurrent use of
anticoagulant with sequential compression devices has shown to be
effective in lowering rates of DVTs and the use of sequential compression
devices alone lowers the risk of hemorrhage, while still being effective
(Pavon et al, 2016).
Early mobilization on post-operative day 1 has also been proven to be
effective in reducing the incidence of DVTs. In a study examining early
mobilization after total knee replacements and incidence of DVT’s found
that the control group showed a 32% incidence of via doppler ultrasound
on post-operative day 1, while the early mobilization group only showed a
14% incidence; this evidence is consistent with other literature studying
early mobilization (Chandrasekaran et al, 2009).

Table 1. Classes of anticoagulants and their indications with considerations of renal function,
laboratory monitoring, major adverse events, and reversal agents.

The majority of DVTs are asymptomatic and the first sign in many patients is a
fatal PE. As discussed earlier, there are many risk factors for having a
thrombotic event in the post-operative patient, but this information must be
applied clinically. Guidelines for anticoagulant prophylaxis use include any
surgical patient over 40 years old or undergoing major general procedures;
prophylaxis should be given prior to surgery or in the perioperative period.
Additionally, patients should ambulate on the day of surgery if they are able,
and the use of sequential compression devices on the lower extremities should
also be implemented. Mechanical methods of DVT prophylaxis such as
sequential compression devices are favored in patients at a high risk for
hemorrhagic complications (Finnerty et al, 2011).

Surgical Indications
The incidence of post-operative DVT differs among the type of
surgery that was performed. A study conducted between 2005 and
2010 on over 2.5 million surgical patients revealed that the incidence
of DVTs was highest among cardiac surgeries with a total incidence
of 2%. Since this study concluded that the incidence of DVTs was
higher among cardiac and vascular surgery patients as compared to
general surgery patients, most cardiac and vascular candidates will
receive therapeutic anticoagulation peri-operatively (Aziz et al,
2015).
The risk of developing a DVT or PE in orthopedic surgeries, such
as a total hip replacement, has been reported to be as high as 20% to
50%. The incidence of pulmonary embolism is twice as high in
orthopedic procedures and five times as high for patients over age 85
(Holzer, 2007). In a study exploring the incidence of DVTs and PEs
in otolaryngological surgeries, a 0.3% incidence of DVTs and 0.2%
incidence of PEs was recorded (Zapanta et al, 2013). It is obvious
based on the available data that there are major discrepancies in
incidence of thromboembolic complications based upon the type of
surgery and further research on the specific procedure must be
performed prior to deciding on a specific anticoagulation regimen.

The Coagulation Cascade
The coagulation cascade involves an interaction between the contact
activation pathway, also known as the intrinsic pathway, and the
tissue factor pathway, also known as the extrinsic pathway. These
two pathways lead to the conversion of Factor X to factor Xa which
is the start of the common pathway; this then converts prothrombin
to thrombin which catalyzes the formation of fibrin and leads to the
stabilization of aggregated platelets to form a stable clot. The
majority of anticoagulants can successfully be classified into the
following categories: vitamin K antagonists, heparins, direct
thrombin inhibitors, and direct factor Xa inhibitors (Morales-Vidal et
al, 2012).

Clinical Applications
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